Follow US:
UC Riverside mouse study focuses on the receptor TNFR1
UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome
UC Riverside-led mouse study finds a receptor greatly contributes to the harmful effects of plastic-associated chemicals
UC Riverside-led team identifies molecular driver and protector of this life-threatening medical emergency
Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
UC Riverside-led study in mice and human tissue is the first to show how a disease mutation weakens barrier properties of epithelial cells lining the gut
UC Riverside experts share their thoughts
UC Riverside mouse study suggests inflammation could play key role in progression to asthma
PANDORA sequencing method developed by UC Riverside-led team can detect once-undetectable small RNAs
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
UC Riverside-led mouse study stresses MS treatment should be started early
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
Host campus UC Riverside will be joined by UC Davis and UC Merced
Neural crest study results could boost stem cell therapies
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
UC Riverside mouse study focused on neurons in the hippocampus
Osmotic therapy device reduces swelling to prevent secondary injuries in rats
